LGALS3 and cardiovascular disorder: Previous studies have shown that increased circulating galectin-3 is associated with the severity of cardiac dysfunction and ventricular remodeling in patients with myocardial infarction [11], acute or chronic HF [12], or even in general population without overt cardiovascular disease [13].